Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis

Scandinavian Journal of Immunology

Volumn 66, Issue 2-3, 2007, Pages 192-198

  Bokarewa, M ^a,b   Tarkowski, A ^b   Magnusson, M ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; SURVIVIN;

ALPHA VIRUS; ARTHRITIS; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLUENZA VIRUS; INTRACELLULAR SPACE; JOINT DESTRUCTION; NONHUMAN; PARVOVIRUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; RUBELLA VIRUS; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 34447344545     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01977.x     Document Type: Review

References (67)

1. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1993 32 : 97 103.
2. van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TW. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 2006 65 : 20 5.
3. Weyand CM, Goronzy JJ. Inherited and noninherited risk factors in rheumatoid arthritis. Curr Opin Rheumatol 1995 7 : 206 13.
4. Yamada R, Suzuki A, Chang X, Yamamoto K. Citrullinated proteins in rheumatoid arthritis. Front Biosci 2005 10 : 54 64.
5. Bokarewa M, Lindblad S, Bokarew D, Tarkowski A. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 2005 7 : R349 58.
6. Svensson B, Hafstrom I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M. Circulating survivin, a novel and independent predictor of joint destruction in early rheumatoid arthritis. Ann Rheum Dis 2007 66 (suppl abstract FRI0190.
7. Branca M, Giorgi C, Santini D et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005 124 : 113 21.
8. Yip KW, Shi W, Pintilie M et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 2006 12 : 5726 32.
9. Mahotka C, Krieg T, Krieg A et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 2002 100 : 30 6.
10. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003 22 : 8581 9.
11. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007 249 : 49 60.
12. Li F, Brattain MG. Role of the survivin gene in pathophysiology. Am J Pathol 2006 169 : 1 11.
13. Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007 28 : 1133 9.
14. Ai MD, Li LL, Zhao XR, Wu Y, Gong JP, Cao Y. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res 2005 15 : 777 84.
15. Borbely AA, Murvai M, Szarka K et al. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 2007 60 : 303 6.
16. Punga T, Akusjarvi G. Adenovirus 2 E1B-55 K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters. FEBS Lett 2003 552 : 214 18.
17. Zhang X, Dong N, Yin L et al. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 2005 77 : 374 81.
18. Zhu Y, Roshal M, Li F, Blackett J, Planelles V. Upregulation of survivin by HIV-1 Vpr. Apoptosis 2003 8 : 71 9.
19. D'Agostino DM, Bernardi P, Chieco-Bianchi L, Ciminale V. Mitochondria as functional targets of proteins coded by human tumor viruses. Adv Cancer Res 2005 94 : 87 142.
20. Morita E, Sugamura K. Human parvovirus B19-induced cell cycle arrest and apoptosis. Springer Semin Immunopathol 2002 24 : 187 99.
21. Franssila R, Hedman K. Infection and musculoskeletal conditions: viral causes of arthritis. Best Pract Res Clin Rheumatol 2006 20 : 1139 57.
22. Balandraud N, Roudier J, Roudier C. What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis? Semin Arthritis Rheum 2005 34 : 31 3.
23. Toussirot E, Auger I, Roudier C et al. HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens 1999 54 : 146 52.
24. Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2006 54 : 733 41.
25. Caliskan R, Masatlioglu S, Aslan M et al. The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int 2005 26 : 7 11.
26. Takahashi Y, Murai C, Ishii T, Sugamura K, Sasaki T. Human parvovirus B19 in rheumatoid arthritis. Int Rev Immunol 1998 17 : 309 21.
27. Aupperle KR, Boyle DL, Hendrix M et al. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 1998 152 : 1091 8.
28. Ray NB, Nieva DR, Seftor EA, Khalkhali-Ellis Z, Naides SJ. Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 2001 44 : 1582 6.
29. Seemayer CA, Kuchen S, Kuenzler P et al. Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 2003 162 : 1549 57.
30. Weber F, Kochs G, Haller O. Inverse interference: how viruses fight the interferon system. Viral Immunol 2004 17 : 498 515.
31. Zare F, Bokarewa M, Nenonen N et al. Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004 172 : 5656 63.
32. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004 303 : 1529 31.
33. Magnusson M, Zare F, Tarkowski A. Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum 2006 54 : 148 57.
34. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 413 : 732 8.
35. Diebold SS, Montoya M, Unger H et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003 424 : 324 8.
36. Yoneyama M, Kikuchi M, Natsukawa T et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004 5 : 730 7.
37. Gitlin L, Barchet W, Gilfillan S et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006 103 : 8459 64.
38. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001 14 : 778 809, table of contents.
39. Parlato S, Santini SM, Lapenta C et al. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 2001 98 : 3022 9.
40. Ruth JH, Shahrara S, Park CC et al. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest 2003 83 : 579 88.
41. Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res 2004 24 : 131 9.
42. Tada Y, Ho A, Matsuyama T, Mak TW. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med 1997 185 : 231 8.
43. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998 67 : 227 64.
44. Hjortsberg L, Lindvall C, Corcoran M et al. Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes. Exp Cell Res 2007 313 : 404 14.
45. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002 277 : 3247 57.
46. Wang Z, Fukuda S, Pelus LM. Survivin regulates the p53 tumor suppressor gene family. Oncogene 2004 23 : 8146 53.
47. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997 94 : 10895 900.
48. Pizzoferrato E, Liu Y, Gambotto A et al. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin. Cancer Res 2004 64 : 8381 8.
49. Asanuma H, Torigoe T, Kamiguchi K et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 2005 65 : 11018 25.
50. You L, He B, Xu Z et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 2004a 64 : 5385 9.
51. You L, He B, Xu Z et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004b 23 : 6170 4.
52. Lu M, Kwan T, Yu C et al. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. J Biol Chem 2005 280 : 6742 51.
53. Fukuda S, Foster RG, Porter SB, Pelus LM. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002 100 : 2463 71.
54. Jonsson M, Engstrom M, Jonsson JI. FLT3 ligand regulates apoptosis through AKT-dependent inactivation of transcription factor FoxO3. Biochem Biophys Res Commun 2004 318 : 899 903.
55. Vollstedt S, Franchini M, Hefti HP et al. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med 2003 197 : 575 84.
56. Ward SG. T lymphocytes on the move: chemokines, PI 3-kinase and beyond. Trends Immunol 2006 27 : 80 7.
57. Clayton E, Bardi G, Bell SE et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 2002 196 : 753 63.
58. Vogt PK, Bader AG, Kang S. Phosphoinositide 3-kinase: from viral oncoprotein to drug target. Virology 2006 344 : 131 8.
59. Mainou BA, Raab-Traub N. LMP1 strain variants: biological and molecular properties. J Virol 2006 80 : 6458 68.
60. Ehrhardt C, Marjuki H, Wolff T et al. Bivalent role of the phosphatidylinositol-3-kinase (PI3 K) during influenza virus infection and host cell defence. Cell Microbiol 2006 8 : 1336 48.
61. Fukao T, Koyasu S. PI3 K and negative regulation of TLR signaling. Trends Immunol 2003 24 : 358 63.
62. Firestein GS. Inhibiting inflammation in rheumatoid arthritis. N Engl J Med 2006 354 : 80 2.
63. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2000 2 : 59 64.
64. Zhang HG, Wang Y, Xie JF et al. Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 2001 44 : 1555 67.
65. Liu H, Perlman H, Pagliari LJ, Pope RM. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med 2001 194 : 113 26.
66. Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum 2002 46 : 31 41.
67. Camps M, Ruckle T, Ji H et al. Blockade of PI3 K gamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005 11 : 936 43.